Oculis Holding AG (OCS)
NASDAQ
OCS price, last 12 months
Key stats
- Previous close
- $7.39
- Open
- $7.46
- Day range
- $7.18 – $7.50
- 52-week range
- $6.78 – $34.48
- Volume
- 154K
- Avg volume (20 days)
- 291.6K
- Market cap
- $425.7M
Performance
Technicals and fundamentals
About Oculis Holding AG
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
- Listed on
- NASDAQ
- Market cap
- $425.7M